ARTICLE BY LOUIS

• Why You Need People Like Jana Spes At Your Company

  Industry veteran Jana Spes provides some uniquely qualified analysis and guidance on the outsourcing industry and working with CDMOs. Don’t be surprised if you come away thinking for your next outsourcing operations hire, specialization is out, and the Spes model is in.

• Award-Winning Questions: “Who Are We?” And “Who Are They?”

  Outsourcing Pharma Chief Editor Louis Garguilo explains what you can expect from this year’s CMO Awards publication and how it can help you when choosing an outsourcing partner.

• When Employees Become The Supply Chain: Leadership In A Pandemic

  With your newly dispersed workforce, employees have in effect become a part of your external supply chain. How can leaders help them get through this time of uncertainty, and continue to perform at a high level? Here's some advice.

• 3 Questions Of Risk And Communication In A Time Of Coronavirus

  Communication with your service providers may turn out most important in getting through immediate coronavirus-induced supply-chain challenges. Outsourcing may have got you into this situation; now it may be the only thing that can get you out. 

• Sign It, President Trump; Don’t Go There, President Xi

  If drugs are discovered as purposefully held up by China to create a supply issue in the U.S., would you ever again employ a China-based CMO? Who would have thought Outsourced Pharma readers would be front and center in presidential politics? But you are.

• Don’t Spread The Wrong Message: COVID-19 And Respect For CMOs

  The first was to be a celebration for safely, reliably, and productively keeping drug development and manufacturing supply chains running. The second is a threat to shut those supply chains down. But here’s a second irony: This new coronavirus may have provided us an opportunity of sorts. 

• COVID-19 No-Fly Zone: A Year And Counting For Biopharma Supply Chains

  “Right now, the coronavirus situation is more about transportation than manufacture,” says one biopharma executive with a global supply chain. “If this continues for more than a year, then I think it'll be getting products manufactured that will really be in play.”

• Will We Learn The Right Lessons From The Coronavirus Crisis?

  What happens – or continues not to happen – next with the coronavirus is critical to the future of global pharmaceutical development and manufacturing industry’s supply chains. But what lessons will we draw from the crisis?

• Coronavirus: Pharma To The Rescue Too Simple

  We may think we’ve been through this before with other coronaviruses such as SARS and MERS … but this time it feels different, like a larger confluence of too many overlapping and unstable tectonic plates.

• Biotechs Will Make Music In The “Twenty-Twenties”

  Outsourced Pharma Chief Editor Louis Garguilo talks with two biotech CEOs about why they believe this industry should expect an infusion of technology and improved productivity in the coming years.